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Purpose: To test the diagnostic power of Pocket Size Imaging Device (PSID) in detecting early signs of right heart
(RH) involvement in regular smokers (RS) free of overt cardiac involvement.
Methods: One-hundred-forty-three regular smokers and 51 healthy controls, comparable for age and sex,
underwent physical exam (PE), PSID exam and standard echocardiography. Based on a simplified Boston score,
≥1 of clinical signs (jugular venous distension, hepatomegaly, peripheral pitting oedema and abnormal pulmonary
sounds) were considered indicative of RH involvement. A composite score (1 to 4) obtained by summing the points
of four quantitative RH abnormalities detectable by PSID (inferior vena cava [IVC] dilatation, reduced IVC respiratory
variation, right ventricular dilatation and right atrial dilatation), was generated and ≥1 of PSID abnormal signs was
considered indicative of RH involvement.
Results: Boston score was not significantly different between the two groups. By using PSID, smokers exhibited
greater IVC diameter (p < 0.0001), right atrial diameter (p < 0.002) and higher PSID score (p < 0.005) than controls.
Compared to PE, the additional diagnostic power of PSID (≥1 abnormal sign of both Boston and PSID score) was
44.9 % in smokers. By dividing smokers in tertiles according to number of cigarettes per day, the third tertile showed
the largest values of both IVC and right atrial dimension. Differences were confirmed by standard echocardiography.
Reproducibility of PSID measurements and concordance of linear measurements between PSID and standard echo
measurements was very good except for concordance of right ventricular basal diameter.
Conclusions: PSID detects early ultrasound signs of RH involvement in regular otherwise healthy smokers in
comparison with PE.
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An estimated 20 % of american adults are regular
smokers [1], without substantial prevalence changes
between 1998 and 2007 [2]. About 443,000 people in
United States and 695.000 in Europe die annually from
“smoking-related” illnesses [3, 4]. Cigarette smoking is a
main determinant of chronic obstructive pulmonary
disease (COPD), which leads to pulmonary arterial* Correspondence: mgalderi@unina.it
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unless otherwise stated.hypertension (PAH) in about 50 % of adults with advanced
COPD [5]. The sequence of changes leading to PAH in
current smokers begins at early stages with endothelial
dysfunction, induced by hypoxia, and inflammation
[6]. Right ventricular (RV) failure is a direct conse-
quence of PAH. The specific mechanisms underlying
the development of RV failure secondary to PAH are
unclear. RV afterload mismatch, myocardial ischemia,
microvascular dysfunction, and myocytes apoptosis
might be involved [7]. Given the difficulty of treating heart
failure with PAH, a primary need correspond to an early
identification of patients at risk of PAH and right heart
(RH) involvement. To date, early markers of RHen Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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standard echocardiography and normal echocardiographic
reference values of right chambers size and of RV function
are recognized [8].
Pocket Size Imaging Device (PSID), an ultrasound
machine which cannot be classified as a standard
echocardiographic machine because of the impossibil-
ity of calculating cardiac volumes and quantifying
valvular flow by pulsed or continuous wave Doppler,
has a potential value as a screening tool [9], because
of its extreme manageability and possible use in mul-
tiple clinical settings. PSID has already shown good
feasibility and accuracy in detecting markers of RH
involvement [10]. Accordingly, the present study was
designed to assess whether PSID may be used to detect
early ultrasound signs and RH involvement in a popula-
tion of asymptomatic regular smokers with or without




The study population included women and men
aged > 40 years, smoking cigarettes since at least
5 years, asymptomatic for dyspnea. The non-smokers
control group, recruited among the staff of the Federico II
University hospital, included healthy subjects who had never
smoked. Obesity (body mass index > 30 Kg/m2), arterial sys-
temic hypertension (systolic blood pressure > 140 mm Hg
and/or diastolic blood pressure > 90 mm Hg or current
antihypertensive treatment) and dyslipidemia (total
cholesterol > 200 mg/dL and or triglycerides > 150 mg/dl)
were not exclusion criteria in both the groups. Patients
with coronary heart disease, primary cardiomyopathies,
more than mild heart valve disease, atrial fibrillation,
congenital heart disease, autoimmune disease, diabetes
mellitus and any kind of renal and/or hepatic diseases
as well as patients taking beta-blocker drugs and/or
diuretics were excluded. The study protocol was approved
by the Institutional Ethical Committee of Federico II
University Hospital and written informed consent was
obtained from all participants.
Procedures
In the same day (morning time between 9 and 11 am)
all the participants underwent sequentially the following
diagnostic steps:
1. A clinical history and complete physical exam
(including measurement of body weight and height,
blood pressure and heart rate) performed in our
outpatient clinic by a clinician (CS);
2. An ultrasound assessment by PSID (Vscan, GE,
Horten, Norway), performed in the same outpatientclinic by two operators (VS-L or RE), blinded to the
physical examination;
3. A complete standard echo-Doppler assessment of
the right ventricle, performed in the echo-lab by a
cardiologist (MG) blind to both the physical exam
and PSID assessment.
Smokers were requested to do not smoke at least two
hours before the performance of the clinical exam and
cardiac ultrasound (PSID and standard echo) assessment.
The following four clinical signs of RH involvement
were considered during physical exam: jugular vein
distension, hepatomegaly with hepato-jugular reflux,
peripheral pitting oedema, pulmonary crackles. The sum
of the points of each sign (0 = absent, 1 = present) was
performed to generate a simplified Boston score, as
previously described [11].
The following four parameters of right heart involvement
were assessed by PSID: 1. maximal (end-expiration) inferior
vena cava diameter (IVC) in subcostal view [12, 13], 2. per
cent respiratory variation of IVC diameter in subcostal view
[12, 13], 3. right atrial (RA) maximal transverse middle
diameter in apical 4-chamber view [8], 4. RV maximal
transverse basal diameter (RV) in apical 4-chamber view
[8]. These four quantitative parameters were used to
generate a composite PSID score by summing the
points (0 = normal value, 1 = abnormal value) of each
parameter. The cut-off values chosen for abnormality
of each PSID parameters were the following:
 maximal (end-expiratory) IVC diameter > 2.0 cm [14],
 percent respiratory variation of IVC < 50 % [8, 14],
 RA maximal transverse middle diameter > 4.5 cm [8],
 RV maximal transverse basal diameter > 4.2 cm [14].
By standard transthoracic echo-Doppler exam we mea-
sured the same above mentioned four parameters and the
following additional parameters, determined according to
standardized procedures of our laboratory [15]:
 tricuspid annular plane systolic excursion (TAPSE) [8],
 tricuspid inflow E/A ratio,
 systolic velocity (s’), early diastolic (e’) and atrial (a’)
velocities of the tricuspid annulus by pulsed Tissue
Doppler,
 retrograde maximal gradient of tricuspid regurgitation
by CW Doppler [16], whenever present.
Both PSID and standard echocardiographic exams were
performed in left lateral decubitus position.
Statistical analyses
Statistical analysis was performed by SPSS package release
12 (SPSS Inc, Chicago, IL, USA). Data are presented as






Jugular pressure (%) 0 (0) 8 (5.3) =0.03
Hepatomegaly (%) 1 (1.9) 5 (3.3) NS
Peripheral oedema (%) 1 (1.9) 4 (2.6) NS
Pulmonary cracles (%) 1 (1.9) 2 (1.3) NS
Boston Score 0.06 ± 0.2 0.10 ± 0.3 NS
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one-factor ANOVA and χ2 distribution with computation
of exact p value by Monte Carlo method. The intra-class
correlation analysis (rho) was used to test the concordance
of the main parameters measured by PSID and standard
echocardiographic machine and also intra- and inter-
observer reproducibility of PSID measurements. The null
hypothesis was rejected at a two-tailed p ≤ 0.05.
Results
The characteristics of the study population are listed in
Table 1. Sex distribution, age, body mass index, blood
pressure and heart rate were comparable between the
two groups.
Table 2 summarizes the data resulting from clinical exam:
Boston score was not significantly different between the
two groups. The frequence of regular smoker exhibiting
at least one clinical sign included in the computation
of Boston Score was 11.3 % (n = 6).
Table 3 reports the PSID findings: IVC diameter
(p < 0.0001) and RA diameter (p < 0.002) were both
higher in regular smokers than in controls. Also
PSID score was higher in regular smokers (p < 0.0001).
PSID (at least one abnormal ultrasound parameter)
extended the detection of RH abnormalities in 86 patients
(56 %) in our regular smokers, with an additional
diagnostic power of 44.9 % (Fig. 1).
Table 4 reports parameters of right heart obtained
by standard echo-Doppler examination: IVC diameter
(p < 0.0001) and RA diameter (p < 0.02) were again
significantly greater in regular smokers than in controls.
Tricuspid regurgitation peak gradient (found in 35
controls and in 128 smokers) and estimated pulmonary
arterial systolic pressure did not differ significantly between
the two groups.
Additional analyses were performed by dividing the
group of smokers in tertiles according to the number
of cigarettes smoked per days (43 smoking 1 to 10Table 1 Characteristics of study population
Variable Controls n = 51 Regular Smokers n = 153 P
Sex (M/F) 24/27 80/71 NS
Age (years) 56.0 ± 7.8 55.5 ± 8.7 NS
BMI (Kg/m2) 26.7 ± 4.2 26.7 ± 3.9 NS
Systolic BP (mm Hg) 131.1 ± 14.1 132.5 ± 19.3 NS
Diastolic BP (mm Hg) 79.2 ± 10.1 79.0 ± 10.0 NS
Heart rate (bpm) 70.7 ± 8.9 70.9 ± 10.2 NS
Hypertension (%, n) 50.9 (26) 49.7 (76) NS
Obesity (%, n) 15.7 (8) 17.0 (26) NS
Diabetes (%, n) 13.7 (7) 13.1 (20) NS
Dyslipidemia (%, n) 37.3 (19) 37.9 (58) NS
BMI = Body mass index, BP = Blood pressurecigarettes/day, 82 smoking 11–20 cigarettes/day and
28 smoking > 20 cigarettes/day). By these analyses
both IVC and RA dimension were significantly larger
in the third tertile (Fig. 2) whereas IVC respiratory
reactivity and RV diameter did not differ significantly
among the three tertiles. These results were confirmed
also using measures derived from standard echo Doppler
exam.
Table 5 shows the intra-class relation coefficients of
linear measurements of the right heart between PSID
and standard echocardiographic machine: the ρ value
was excellent except for RV basal diameter. Also the
reproducibility of PSID measurements (data not
shown in table) was optimal: rho IVC diameter = 0.96
intra and 0.93 inter-observer, % IVC respitatory vari-
ation = 0.97 and 0.96 respectively, RA diameter = 0.98
and 0.96, RV diameter = 0.92 and 0.95).
Discussion
PSID is a novel, ultraportable ultrasound machine which
provides black and white and colour flow imaging in
real-time and allows to calculate only linear measure-
ments and areas of the heart structures. PSID has been
already used to complement and extent physical exam
[9, 10, 17–20]. Its main cardiac applications include
eye-ball quantitation of left ventricular (LV) function
[10, 21], detection of LV [9, 19, 21] and RV abnormalities
[9], pericardial effusion [9, 21], valve regurgitations [9, 21],






IVC diameter (cm) 1.32 ± 0.3 1.59 ± 0.4 <0.0001
Respiratory Variation (%) 51.0 ± 8.3 48.9 ± 9.9 NS
RA diameter (cm) 3.13 ± 0.5 3.39 ± 0.5 <0.002
RV basal diameter (cm) 3.35 ± 0.5 3.49 ± 0.5 NS
PSID Score 0.27 ± 0.5 0.65 ± 0.7 <0.005
IVC dilation (%, n) 2 (1) 8.5(13) <0.05
Pathological % resp
variation (%, n)
5.9 (3) 17 (26) =0.03
RA dilation (%, n) 0 (0) 3.3 (5) =0.07
RV dilation (%, n) 3.9 (2) 2.6 (4) NS
Fig. 1 Head to head comparison of the rate of regular smokers with
at least one abnormality in simplified Boston score and PSID score.
PSID additional diagnostic power appears to be of 44.9 %
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detection of cardiac involvement in subclinical stages of
heart diseases [9], a potentiality which has been poorly
investigated.
The present study is the first to apply PSID to the
detection of preclinical markers of RH involvement in
asymptomatic regular smokers and reveals that PSID
might be useful as a screening tool in this specific
clinical setting. We demonstrate that PSID can add
useful information to the simple physical exam of theseTable 4 Standard Echo Doppler Data of the right ventricle
Variable Controls n = 51
Tricuspid regurgitation gradient (mmHg)* 20.6 ± 5.5
PAPs (mm Hg)* 25.5 ± 5.5
IVC diameter (cm) 1.33 ± 0.31
Respiratory Variation (%) 51.2 ± 8.42
RA diameter (cm) 3.20 ± 0.42
RV basaldiameter (cm) 2.89 ± 0.45
RV longitudinal diameter (cm) 6.09 ± 0.69
TAPSE (cm) 23.1 ± 3.45
Tricuspid E/A ratio 1.16 ± 0.33
Tricuspid annular s’ (cm/s) 0.14 ± 0.3
Tricuspid annular e’ (cm/s) 0.12 ± 0.3
Tricuspid annular a’ (cm/s) 0.14 ± 035subjects who represent a high risk population for develop-
ment of PAH and RV failure.
The choice of PSID measurements of right heart we
used in the present study has a solid rationale. Maximal
diameter and percent respiratory variation of IVC have
prognostic value in patients with PAH [12, 24], a recog-
nized complication of smoking habit, with the intermedi-
ate condition of COPD [5]. The diameters of the right
atrium and right ventricle are also used in the clinical
practice as markers of RA and RV dilation respectively [8].
We also generated a composite PSID score determining
the total amount of abnormalities for each measurement
according to cut-off values of current echo recommenda-
tions [8, 14] and comparing this PSID score to the purely
clinical simplified Boston score.
Among the examined parameters, IVC respiratory
variation and RV diameter did not differ between the two
groups, by using both PSID and standard echocardiog-
raphy. This is likely due to the very early assessment, well
before initial symptoms and signs associated with the
presence of PAH [12, 25, 26]. However, the evidence of
higher IVC size in regular smokers was strengthened by
the higher RA diameter. While it is difficult to attribute
the increased size of these two parameters to an early
increase of RA pressure, it is possible to conceive that
nicotine, as a venoconstrictor and sympatethic nervous
activator, could have induced central shifting of splanchnic
venous blood flow towards IVC and right atrium, causing
both to become plethoric. Chronic smokers can have a
sustained chronic increase in sympathetic nerve activity
due to blunted baroreflexes [27].
The PSID composite score, generated after using recog-
nized clear-cut abnormal values of the four chosen param-
eters (IVC size and respiratory reactivity, RA and RV
diameter) was significantly higher in regular smokers than
in controls. In contrast, the simplified Boston score didRegular Smokers n = 153 P
20.6 ± 6.4 NS
26.6 ± 7.1 NS
1.59 ± 0.36 <0.0001
48.7 ± 10.6 NS
3.43 ± 0.57 <0.02
3.02 ± 0.47 NS
6.15 ± 0.77 NS
23.6 ± 3.99 NS
1.15 ± 0.44 NS
0.13 ± 0.2 NS
0.12 ± 0.3 NS
0.15 ± 0.35 NS
Fig. 2 IVC and RA size of regular smokers according to tertiles of cigarettes smoked per day. RA = Right atrial, IVC = Inferior vena cava
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groups. By comparing Boston and PSID score in smokers
(at least 1 abnormal sign/parameter included in both the
scores), PSID showed a 44.9 % increase in the capacity of
detecting RH involvement in our regular smokers.
The simple physical exam has obvious limitations for
diagnosis of heart involvement in subclinical cardiac
diseases [28, 29]. A novel clinical approach including
the additional support of hand-held echocardiography
was already proposed [30–34] and refined combining
physical exam and PSID, by a purely visual, clear-cut
assessment of main parameters [10]. The present
study further extends these findings and the potential
indications for the use of PSID.
An additional finding of our study is provided by the
analyses we performed dividing the smoker population
according to tertiles of daily smoked cigarettes. These
analyses was done to highlight possible graduality effect
of smoking habit on PSID parameters. Both IVC and RA
diameter were larger in the third tertile, i.e. in smokers
of more than 20 cigarettes/day. These results, found also
by using standard echo machine, highlight further the well










IVC diameter (cm) 0.894 0.860 0.919
IVC percent variation 0.932 0.910 0.949
RA diameter (cm) 0.806 0.745 0.853
RV basal diameter (cm) 0.472 0.304 0.599vascular structure [6]. They point out that this effect is
proportional to the intensity of nicotine exposure [27].
Globally, the results of the present study are reinforced
by the good intra- and inter-observer reproducibility of
PSID measurements and by the good intra-class relation
coefficients between PSID and standard echo measure-
ments of the right heart. These coefficients were very
good for all the quantitative parameters analyzed, with the
exception of RV diameter. The difficulty of obtaining a
definite border delineation of RV chamber size in apical
4-chamber view by using PSID can explain the weakness
of RV diameter using PSID.
Study limitations
The main limitation of the use of PSID in the explored
clinical context was the impossibility of obtaining a non
invasive estimation of tricuspid regurgitation gradient
and of pulmonary arterial pressure. This contributes to
differentiate substantially PSID from a standard echo
instrumentation. Accordingly, we a priori decided to
do not use the simple color assessment of tricuspid regur-
gitation in our composite PSID score. Although tricuspid
regurgitation can be visualized by color Doppler of PSID,
the diagnostic accuracy of PSID in distinguishing marginal
from clinically significant regurgitation has been found to
be poor [10, 20], mainly because of the fix pulse-repetition
frequency of PSID which debars an effective graduation of
valvular regurgitations.
Another limitation corresponds to the lack of any kind
of estimation of RV systolic function and of RA volume
by using PSID. Very recent 2015 echo recommendations
on chamber quantification encourage the use of RA
volume as the most reliable parameter of RA size [35].
However, volumes cannot be estimated by PSID and our
study was conceived before the publications of these new
recommendations.
Schiano-Lomoriello et al. Cardiovascular Ultrasound  (2015) 13:33 Page 6 of 7The lack of data on lung function tests (e.g. spirometry)
and on biomarkers (BNP and/or pro-BNP), not performed
because of the screening nature of our asymptomatic
smokers, could have been useful to better refine the clinical
picture of these subjects and could be considered as a
further study limitation.
Conclusions
We demonstrate that the prompt technology of PSID
provides the ability of detecting RH involvement in regu-
lar asymptomatic smokers. These data are consistent
with an early RV longitudinal dysfunction observed in
young, asymptomatic smoker buy using standard echo
and strain rate imaging [36]. Changes of both IVC and
RA size found in our asymptomatic smokers could be
explained on the basis of the venoconstrictor effects of
nicotine, able to shift the venous blood flow towards the
right venous circulation, thus inducing a IVC overload.
PSID might be therefore proposed as an useful screening
tool in this clinical setting.
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